earnings
confidence high
sentiment positive
materiality 0.65
Arcadia Biosciences Q3 revenue up 18% to $1.5M; net loss narrows to $1.6M
Arcadia Biosciences, Inc.
2024-Q3 EPS reported
-$2.18
revenue$3,829,000
- Total revenues $1.537M, +18% YoY; Zola coconut water revenue +55% YoY.
- Zola retail distribution expanded 68% vs Q3 2023.
- Net loss attributable to common stockholders $1.612M ($1.18/share) vs $2.567M ($1.89) in Q3 2023.
- Operating expenses increased 22% to $3.297M due to higher revenues and severance costs.
- Cash and cash equivalents $3.936M, down from $6.518M at Dec 31, 2023.